She has not been marketed since the InMed deal fell through in 2018 when old management was marketing her. She lost all her value on very low volume from not being marketing in like 6 years. Since then new management was appointed. They did a share restructure, a company name change. a ticker change, filled and approved to drop their shell status, Major Growth with Over $11 Million in Revenue, and a ton of other great things including protecting their unrestricted share count (float) like no other company in the OTC. One thing new management has not done yet is start to market her. If you are lucky enough to get some shares down here then your bonus gains will be sick by the time she passes .30 so don't complain. 🤑
"ATMH = a long history of doing nothing but going down, ATMH goes from $.30 down to $.049, DOWN OVER -80%, how pitiful is that."
If you understood share structures you would know a 2.9 million unrestricted share count https://www.otcmarkets.com/stock/ATMH/security is setup to trade in the multi dollar range. It wont happen till they start marketing her though so don't expect it to. How will they create new interest before they start their marketing campaign? They can't and they are not trying to right now because they are not trying to use the market for anything. That's the reason why we can buy this micro 2.9 million unrestricted share count ticker for under .05 cents right now. Get them while you can before their marketing campaign begins. 🤑
Market Data 
Markets 
AI
